Neonatal hyperbilirubinemia - What are the risks?

New England Journal of Medicine

Volumn 354, Issue 18, 2006, Pages 1947-1949

  Watchko, Jon F ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

BEHAVIOR DISORDER; BRAIN DAMAGE; COGNITIVE DEFECT; CYTOTOXICITY; EDITORIAL; FOLLOW UP; GESTATIONAL AGE; HEMOLYSIS; HOSPITALIZATION; HUMAN; KERNICTERUS; MEDICAL LITERATURE; MOTOR DYSFUNCTION; NERVOUS SYSTEM INJURY; NEWBORN JAUNDICE; PHOTOTHERAPY; PRIORITY JOURNAL; RISK FACTOR; VISUOMOTOR COORDINATION; BLOOD; CHILD DEVELOPMENT; EXCHANGE BLOOD TRANSFUSION; NEWBORN; NOTE; OUTCOME ASSESSMENT;

BILIRUBIN; CHILD DEVELOPMENT; EXCHANGE TRANSFUSION, WHOLE BLOOD; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; OUTCOME ASSESSMENT (HEALTH CARE); PHOTOTHERAPY;

EID: 33646372001     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe068053     Document Type: Editorial

References (15)

1. Bhutani VK, Johnson LH, Maisels MJ, et al. Kernicterus: epidemiological strategies for its prevention through systems-based approaches. J Perinatol 2004;24:650-62.
2. Perlstein MA. The late clinical syndrome of posticteric encephalopathy. Pediatr Clin North Am 1960;7:665-87.
3. Maisels MJ, Newman TB. Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics 1995;96:730-3.
4. Ip S, Chung M, Kulig J, et al. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics 2004;114:e130-e153.
5. Ebbesen F. Recurrence of kernicterus in term and near-term infants in Denmark. Acta Paediatr 2000;89:1213-7.
6. Hansen TWR. Kernicterus: an international perspective. Semin Neonatol 2002;7:103-9.
7. Kaplan M, Hammerman C. Understanding and preventing severe neonatal hyperbilirubinemia: is bilirubin neurotoxicity really a concern in the developed world? Clin Perinatol 2004;31:555-75.
8. Ryan AS, Wenjun Z, Acosta A. Breastfeeding continues to increase into the new millennium. Pediatrics 2002;110:1103-9.
9. Curtin SC, Kozak LJ. Decline in U.S. Cesarean delivery rate appears to stall. Birth 1998;25:259-62.
10. Watchko JF. Vigintiphobia revisited. Pediatrics 2005;115:1747-53.
11. Kaplan M, Hammerman C. Bilirubin and the genome: the hereditary basis of unconjugated neonatal hyperbilirubinemia. Curr Pharmacogenomics 2005;3:21-42.
12. Newman TB, Liljestrand P, Jeremy RJ, et al. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. N Engl J Med 2006;354:1889-900.
13. Maisels MJ. Epidemiology of neonatal jaundice. In: Maisels MJ, Watchko JF, eds. Neonatal jaundice. Monographs in clinical pediatrics. Vol. 11. Amsterdam: Harwood Academic, 2000:37-49.
14. Ozmert E, Erdem G, Topcu M, et al. Long-term follow-up of indirect hyperbilirubinemia in full-term Turkish infants. Acta Paediatr 1996;85:1440-4.
15. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297-316. [Erratum, Pediatrics 2004;114:1138.]